GlassScriptPhysician profile
Dali Feng
NPI 1215917646
$2,524.58
in general payments reported to CMS, 2019-2025
12 companies · $311 in 2025
The $311 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $720 · 2020: $163 · 2022: $883 · 2023: $398 · 2024: $49.71 · 2025: $311.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $759.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $759.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Siemens Medical Solutions USA, INC. | $985.99 | 2019-2022 | |
| Edwards Lifesciences Corporation | $589.41 | 2019-2025 | Sapien 3 Ultra Resilia |
| Heartflow, INC. | $185.59 | 2023-2025 | Ffrct |
| Abbott Laboratories | $175.51 | 2023-2025 | Coroflow, Thoratec Heartmate 3 Lvas Implant Kit, Mitraclip |
| Boston Scientific Corporation | $148.09 | 2019-2024 | Watchman Access System |
| Ge Healthcare | $116.91 | 2025 | |
| Cleerly, INC. | $101.47 | 2025 | Cleerly Labs, Cleerly Ischemia |
| Medtronic Vascular, INC. | $89.00 | 2019 | |
| Canon Medical Systems USA, INC. | $67.51 | 2019 | |
| Medtronic, INC. | $26.92 | 2023 | Corevalve Evolut R |
| Daxor Corporation | $22.41 | 2024 | Bva-100 |
| Novartis Pharmaceuticals Corporation | $15.77 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dali Feng listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.